Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05473273 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 30, 2025 to Dec 30, 2026v6
  2. Primary completion date: Dec 31, 2023 to Dec 30, 2025
    • Study completion date: Jan 30, 2024 to Dec 30, 2025
    • Site details revised
    v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2023 to Apr 24, 2023
    • Site details revised
    v4
  4. Start date: Nov 15, 2022 to Mar 1, 2023v3 Show 4 more changesShow less
    • Trial status: Recruiting to Not Yet Recruiting
    • Primary completion date: Nov 15, 2023 to Dec 31, 2023
    • Study completion date: Dec 30, 2023 to Jan 30, 2024
    • Site details revised
  5. Trial status: Not Yet Recruiting to Recruitingv2 Show 9 more changesShow less
    • Start date: Aug 15, 2022 to Nov 15, 2022
    • Primary endpoints revised (51)
    • Primary completion date: Aug 15, 2023 to Nov 15, 2023
    • Study completion date: Sep 30, 2023 to Dec 30, 2023
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 1 of 3 entries
    • Study description expanded, about 27 words
    • Site details revised
    • Study title revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To describe the peripheral serum levels of the anti-inflammatory cytokines IL-4 (Interleukin-4), IL-10 (Interleukin-10), TGF-ß1 (Transforming Growth Factor beta1), the pro-inflammatory cytokines IL-17 (Interleukin-17), IFγ (Interferon Gamma) and the immune mediator PIBF (Progesterone-Induced Blocking Factor) along a single frozen euploid blastocyst transfer in a natural cycle (NC) or Hormone Replacement Therapy (HRT).
Trial Details
NCT Number NCT05473273
Lead Sponsor ART Fertility Clinics LLC
Conditions
(from sponsor)		 Infertility, Female
Related terms Infertility, Female, Long Qt Syndrome 3
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov